Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 7.13
+0.08 (1.13%)
Jan 23, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 6.5 | 31.09 | -10.75 | 18.23 | -118.91 | 161.71 | Upgrade |
Depreciation & Amortization | 112.01 | 112.01 | 112.09 | 138.27 | 167.86 | 155.32 | Upgrade |
Other Amortization | 4.94 | 4.94 | 6.22 | 4.61 | 9.03 | 2.02 | Upgrade |
Loss (Gain) From Sale of Assets | -3.01 | -3.01 | -0.05 | 0.06 | 0.23 | -0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 7.87 | 7.87 | 12.95 | 0.43 | 82.47 | 1.71 | Upgrade |
Loss (Gain) From Sale of Investments | -12.21 | -12.21 | -5.38 | -156.82 | 2.28 | -9.43 | Upgrade |
Provision & Write-off of Bad Debts | 1.44 | 1.44 | -16.78 | -0.17 | 34.95 | 14.36 | Upgrade |
Other Operating Activities | -2.32 | 11.25 | 24.46 | 54.6 | 115.84 | 100.09 | Upgrade |
Change in Accounts Receivable | -25.38 | -25.38 | 27.66 | 154.07 | 11.84 | 11.92 | Upgrade |
Change in Inventory | -2.6 | -2.6 | 13.39 | -28.43 | 13.84 | 14.24 | Upgrade |
Change in Accounts Payable | -51.76 | -51.76 | -5.88 | 57.23 | -82.71 | -47.34 | Upgrade |
Operating Cash Flow | 31.03 | 69.19 | 154.4 | 249.77 | 216.93 | 403.73 | Upgrade |
Operating Cash Flow Growth | -84.49% | -55.19% | -38.18% | 15.14% | -46.27% | -8.69% | Upgrade |
Capital Expenditures | -293.46 | -377.4 | -394.17 | -197.78 | -162.98 | -283.04 | Upgrade |
Sale of Property, Plant & Equipment | 0.51 | 0.79 | 0.22 | 0.02 | 0.02 | 0.04 | Upgrade |
Cash Acquisitions | 80.57 | -9.1 | - | -4.06 | -91.15 | -11.8 | Upgrade |
Divestitures | - | - | - | 1,201 | - | -2.24 | Upgrade |
Investment in Securities | 400.21 | 287.97 | 519.48 | -1,432 | -0.62 | -14.33 | Upgrade |
Other Investing Activities | -107.37 | 16.78 | 16.68 | 21.91 | 0.19 | 0.01 | Upgrade |
Investing Cash Flow | 80.47 | -80.95 | 142.22 | -411.31 | -254.53 | -311.37 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 5 | Upgrade |
Long-Term Debt Issued | - | 35 | 89.35 | 429.9 | 901.5 | 843.26 | Upgrade |
Total Debt Issued | 130.5 | 35 | 89.35 | 429.9 | 901.5 | 848.26 | Upgrade |
Long-Term Debt Repaid | - | -49.83 | -115 | -710.28 | -825.39 | -885.3 | Upgrade |
Net Debt Issued (Repaid) | 86.6 | -14.83 | -25.65 | -280.38 | 76.11 | -37.04 | Upgrade |
Issuance of Common Stock | 3.03 | - | 0.95 | - | - | 98 | Upgrade |
Repurchase of Common Stock | - | - | -39.06 | -61.05 | - | - | Upgrade |
Common Dividends Paid | -55.38 | -34.55 | -51.06 | -61.94 | -69.98 | -63.7 | Upgrade |
Other Financing Activities | -154.52 | 92.43 | -99.42 | 480.24 | 30.49 | -2.05 | Upgrade |
Financing Cash Flow | -120.27 | 43.05 | -214.25 | 76.87 | 36.62 | -4.8 | Upgrade |
Foreign Exchange Rate Adjustments | -0.35 | -2.62 | 0.6 | 2.08 | -0.33 | 0.55 | Upgrade |
Net Cash Flow | -9.12 | 28.67 | 82.97 | -82.58 | -1.31 | 88.11 | Upgrade |
Free Cash Flow | -262.43 | -308.2 | -239.77 | 51.99 | 53.95 | 120.68 | Upgrade |
Free Cash Flow Growth | - | - | - | -3.64% | -55.29% | 172.69% | Upgrade |
Free Cash Flow Margin | -31.59% | -37.30% | -30.12% | 4.43% | 2.85% | 6.30% | Upgrade |
Free Cash Flow Per Share | -0.54 | -0.63 | -0.49 | 0.11 | 0.11 | 0.26 | Upgrade |
Cash Income Tax Paid | 40.5 | 35.63 | 31.9 | 87.51 | 89.61 | 28.99 | Upgrade |
Levered Free Cash Flow | -248.52 | -258.8 | -240.05 | 778.97 | 70.6 | -16.1 | Upgrade |
Unlevered Free Cash Flow | -245.32 | -254.73 | -238.29 | 791.32 | 92.11 | 13 | Upgrade |
Change in Working Capital | -84.19 | -84.19 | 31.64 | 190.57 | -76.82 | -22.03 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.